Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578387 | 1.00 | ALDH1A1 (0.33) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL23972 | 0.90 | ALDH1A1 (0.52) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| Methane SCHEMBL28251706 | 0.88 | ALDH1A1 (0.50) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL2408200 | 0.86 | ALDH1A1 (0.31) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL5746196 | 0.82 | ALDH1A1 (0.55) | ALDH1A1CYP1A2CYP3A4HPGDTSHR | |
| SCHEMBL5748360 | 0.82 | ALDH1A1 (0.55) | ALDH1A1CYP1A2CYP3A4HPGDTSHR | |
| SCHEMBL5747748 | 0.82 | CYP1A2 (0.36) | ALDH1A1CYP1A2CYP3A4HPGDTSHR | |
| SCHEMBL2408326 | 0.82 | ALDH1A1 (0.39) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL15351773 | 0.81 | ALDH1A1 (0.31) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL2409845 | 0.79 | ALDH1A1 (0.40) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115524371-A | Application of covalent organic-inorganic hybrid superlattice material as chemical resistance type gas sensitive material | 闽都创新实验室 | 2022-12-27 | — | — | CN | claimed |
| EP-0964045-B1 | Polymeric fluorescent substance and organic electroluminescence device | SUMITOMO CHEMICAL CO (JP) | 2004-10-06 | — | — | EP | claimed |
| US-6403237-B1 | POLYMER CONTAINING UNSATURATED AROMATIC MONOMER HEAT RESISTANCE; ORANGE TO RED; TRANSPARENT ANODE OR CATHODE | SUMITOMO CHEMICAL CO., LTD. (JP) | 2002-06-11 | — | — | US | claimed |
| EP-0964045-A1 | Polymeric fluorescent substance and organic electroluminescence device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | claimed |
| US-20240197888-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | 2024-06-20 | — | — | US | disclosed |
| US-20240190883-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2024-06-13 | — | — | US | disclosed |
| US-20240190885-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX INC (US) | 2024-06-13 | — | — | US | disclosed |
| US-20240174643-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| EP-4355741-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | Biotheryx, Inc. (US) | 2024-04-24 | — | — | EP | disclosed |
| US-20240124418-A1 | PDE4 DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX INC (US) | 2024-04-18 | — | — | US | disclosed |
| US-20240116845-A1 | INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | NUCMITO PHARMACEUTICALS CO LTD (CN) | 2024-04-11 | — | — | US | disclosed |
| EP-2208745-A1 | POLYMER COMPOUND, METHOD FOR PRODUCING THE SAME, AND COMPOSITION CONTAINING THE POLYMER COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-07-21 | — | — | EP | disclosed |
| US-20100156284-A1 | ANTHRACENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2159244-A1 | ANTHRACENE POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-03-03 | — | — | EP | disclosed |
| EP-2147944-A1 | PYRENE POLYMER AND LUMINESCENT ELEMENT MADE WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-01-27 | — | — | EP | disclosed |
| EP-0964045-B1 | Polymeric fluorescent substance and organic electroluminescence device | SUMITOMO CHEMICAL CO (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-6403237-B1 | POLYMER CONTAINING UNSATURATED AROMATIC MONOMER HEAT RESISTANCE; ORANGE TO RED; TRANSPARENT ANODE OR CATHODE | SUMITOMO CHEMICAL CO., LTD. (JP) | 2002-06-11 | — | — | US | disclosed |
| EP-0964045-A1 | Polymeric fluorescent substance and organic electroluminescence device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190885-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | KRAS, NRAS, APC | ALDH1A1 3269/4885CYP1A1 1831/4885CYP1A2 3268/4885 |
| US-20240197888-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | SOS1, SOS2, SOST | ALDH1A1 3564/4885CYP1A1 1850/4885CYP1A2 2874/4885 |
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | TERB1, AHR, CYP1A1 | ALDH1A1 1933/4885CYP1A1 3/4885CYP1A2 21/4885 |
| US-20240174643-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | SOS1, SOS2, SOST | ALDH1A1 3542/4885CYP1A1 1825/4885CYP1A2 2856/4885 |
| US-20240124418-A1 | PDE4 DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | PDE4A, PDE4B, PDE12 | ALDH1A1 322/4885CYP1A1 584/4885CYP1A2 215/4885 |
| US-20240116845-A1 | INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | MMP1, IDO1, COL1A1 | ALDH1A1 120/4885CYP1A1 128/4885CYP1A2 24/4885 |
| US-20240190883-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | KRAS, NRAS, APC | ALDH1A1 3188/4885CYP1A1 1700/4885CYP1A2 3086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.